Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Viral Vaccines
Revenue, means the sales value of Viral Vaccines
This report studies Viral Vaccines in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Attenuated Vaccine
Inactivated Vaccine
Split by Application, this report focuses on consumption, market share and growth rate of Viral Vaccines in each application, can be divided into
Hospital
Pharmaceutical Factory
Research Institute
Other
China Viral Vaccines Market Research Report 2017
1 Viral Vaccines Market Overview
1.1 Product Overview and Scope of Viral Vaccines
1.2 Viral Vaccines Segment by Type
1.2.1 China Production Market Share of Viral Vaccines Type in 2015
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Applications of Viral Vaccines
1.3.1 Viral Vaccines Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Other
1.4 China Market Size (Value) of Viral Vaccines (2012-2022)
1.5 China Viral Vaccines Status and Outlook
1.6 Government Policies
2 China Viral Vaccines Market Competition by Manufacturers
2.1 China Viral Vaccines Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Viral Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Viral Vaccines Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Viral Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Viral Vaccines Market Competitive Situation and Trends
2.5.1 Viral Vaccines Market Concentration Rate
2.5.2 Viral Vaccines Market Share of Top 3 and Top 5 Manufacturers
3 China Viral Vaccines Manufacturers Profiles/Analysis
3.1 GSK
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Viral Vaccines Product Type, Application and Specification
3.1.2.1 Attenuated Vaccine
3.1.2.2 Inactivated Vaccine
3.1.3 GSK Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Merck
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Viral Vaccines Product Type, Application and Specification
3.2.2.1 Attenuated Vaccine
3.2.2.2 Inactivated Vaccine
3.2.3 Merck 124 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Novartis
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Viral Vaccines Product Type, Application and Specification
3.3.2.1 Attenuated Vaccine
3.3.2.2 Inactivated Vaccine
3.3.3 Novartis 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Pfizer
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Viral Vaccines Product Type, Application and Specification
3.4.2.1 Attenuated Vaccine
3.4.2.2 Inactivated Vaccine
3.4.3 Pfizer Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Sanofi
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Viral Vaccines Product Type, Application and Specification
3.5.2.1 Attenuated Vaccine
3.5.2.2 Inactivated Vaccine
3.5.3 Sanofi Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Bayer
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Viral Vaccines Product Type, Application and Specification
3.6.2.1 Attenuated Vaccine
3.6.2.2 Inactivated Vaccine
3.6.3 Bayer Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Zoetis
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Viral Vaccines Product Type, Application and Specification
3.7.2.1 Attenuated Vaccine
3.7.2.2 Inactivated Vaccine
3.7.3 Zoetis Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 AstraZeneca
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Viral Vaccines Product Type, Application and Specification
3.8.2.1 Attenuated Vaccine
3.8.2.2 Inactivated Vaccine
3.8.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Johnson
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Viral Vaccines Product Type, Application and Specification
3.9.2.1 Attenuated Vaccine
3.9.2.2 Inactivated Vaccine
3.9.3 Johnson Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 CSL
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Viral Vaccines Product Type, Application and Specification
3.10.2.1 Attenuated Vaccine
3.10.2.2 Inactivated Vaccine
3.10.3 CSL Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
4 China Viral Vaccines Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Viral Vaccines Capacity, Production and Growth (2012-2017)
4.2 China Viral Vaccines Revenue and Growth (2012-2017)
4.3 China Viral Vaccines Production, Consumption, Export and Import (2012-2017)
5 China Viral Vaccines Production, Revenue (Value), Price Trend by Type
5.1 China Viral Vaccines Production and Market Share by Type (2012-2017)
5.2 China Viral Vaccines Revenue and Market Share by Type (2012-2017)
5.3 China Viral Vaccines Price by Type (2012-2017)
5.4 China Viral Vaccines Production Growth by Type (2012-2017)
6 China Viral Vaccines Market Analysis by Application
6.1 China Viral Vaccines Consumption and Market Share by Application (2012-2017)
6.2 China Viral Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaViral Vaccines Market Analysis by Regions (Provinces)
7.1 China Viral Vaccines Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Viral Vaccines Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Viral Vaccines Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Viral Vaccines Sales Price by Regions (Provinces)(2012-2017)
7.2 China Viral Vaccines Consumption by Regions (Provinces)(2012-2017)
7.3 China Viral Vaccines Production, Consumption, Export and Import (2012-2017)
8 Viral Vaccines Manufacturing Cost Analysis
8.1 Viral Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Viral Vaccines
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Viral Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Viral Vaccines Market Forecast (2017-2022)
12.1 China Viral Vaccines Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Viral Vaccines Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Viral Vaccines Production Forecast by Type (2017-2022)
12.4 China Viral Vaccines Consumption Forecast by Application (2017-2022)
12.5 China Viral Vaccines Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Viral Vaccines Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Viral Vaccines Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Viral Vaccines Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Viral Vaccines Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Viral Vaccines
Figure China Production Market Share of Viral Vaccines by Type in 2015
Figure Product Picture of Attenuated Vaccine
Table Major Manufacturers of Attenuated Vaccine
Figure Product Picture of Inactivated Vaccine
Table Major Manufacturers of Inactivated Vaccine
Table Viral Vaccines Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Pharmaceutical Factory Examples
Figure Research Institute Examples
Figure Other Examples
Figure China Viral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Table China Viral Vaccines Capacity of Key Manufacturers (2015 and 2016)
Table China Viral Vaccines Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Viral Vaccines Capacity of Key Manufacturers in 2015
Figure China Viral Vaccines Capacity of Key Manufacturers in 2016
Table China Viral Vaccines Production of Key Manufacturers (2015 and 2016)
Table China Viral Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Viral Vaccines Production Share by Manufacturers
Figure 2016 Viral Vaccines Production Share by Manufacturers
Table China Viral Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Viral Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Viral Vaccines Revenue Share by Manufacturers
Table 2016 China Viral Vaccines Revenue Share by Manufacturers
Table China Market Viral Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Viral Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Viral Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Viral Vaccines Product Type
Figure Viral Vaccines Market Share of Top 3 Manufacturers
Figure Viral Vaccines Market Share of Top 5 Manufacturers
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Viral Vaccines Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Viral Vaccines Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Viral Vaccines Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Viral Vaccines Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Viral Vaccines Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Viral Vaccines Market Share (2012-2017)
Table Zoetis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zoetis Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Zoetis Viral Vaccines Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Viral Vaccines Market Share (2012-2017)
Table Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson Viral Vaccines Market Share (2012-2017)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Viral Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Viral Vaccines Market Share (2012-2017)
Figure China Viral Vaccines Capacity, Production and Growth (2012-2017)
Figure China Viral Vaccines Revenue (Million USD) and Growth (2012-2017)
Table China Viral Vaccines Production, Consumption, Export and Import (2012-2017)
Table China Viral Vaccines Production by Type (2012-2017)
Table China Viral Vaccines Production Share by Type (2012-2017)
Figure Production Market Share of Viral Vaccines by Type (2012-2017)
Figure 2015 Production Market Share of Viral Vaccines by Type
Table China Viral Vaccines Revenue by Type (2012-2017)
Table China Viral Vaccines Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Viral Vaccines by Type (2012-2017)
Figure 2015 Revenue Market Share of Viral Vaccines by Type
Table China Viral Vaccines Price by Type (2012-2017)
Figure China Viral Vaccines Production Growth by Type (2012-2017)
Table China Viral Vaccines Consumption by Application (2012-2017)
Table China Viral Vaccines Consumption Market Share by Application (2012-2017)
Figure China Viral Vaccines Consumption Market Share by Application in 2015
Table China Viral Vaccines Consumption Growth Rate by Application (2012-2017)
Figure China Viral Vaccines Consumption Growth Rate by Application (2012-2017)
Table China Viral Vaccines Production by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Production Market Share by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Production Value by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Sales Price by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Consumption by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Viral Vaccines Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vaccines
Figure Manufacturing Process Analysis of Viral Vaccines
Figure Viral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral Vaccines
Table Distributors/Traders List
Figure China Viral Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table China Viral Vaccines Production, Import, Export and Consumption Forecast (2017-2022)
Table China Viral Vaccines Production Forecast by Type (2017-2022)
Table China Viral Vaccines Consumption Forecast by Application (2017-2022)
Table China Viral Vaccines Production Forecast by Regions (Provinces)(2017-2022)
Table China Viral Vaccines Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Viral Vaccines Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...